Nicole Wetsman / The Verge:
Alphabet launches Isomorphic Laboratories, a company that uses AI for drug discovery; DeepMind CEO Demis Hassabis will also serve as Isomorphic CEO — It builds on DeepMind’s work on protein folding — A new Alphabet company will use artificial intelligence methods for drug discovery, Google’s parent company announced Thursday.
You may also like
Alan Boyle / GeekWire: Phoenix-based Mangata, which is building a satellite constellation for connectivity and edge computing for 2024, raises a $33M […]
Queenie Wong / CNET: Facebook says it is testing a way for users to create up to five profiles linked to one […]
Enlarge / Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration, testifies during […]
FinSMEs: GridX, which offers rate analytics and billing software to utilities and energy tech companies, raises a $40M Series C led by […]